BESSEMER GROUP INC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1054074 WOODBRIDGE, NJ

Position in LGND

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$21,534,046

+$17,089,012 QoQ

Shares Held

107,859

+358.8% QoQ

Ownership

0.538%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 99.76079882068257.ToString("F0")% Shared 0.ToString("F0")% None 0.23920117931744223.ToString("F0")%

Healthcare · as of Mar 31, 2026

BESSEMER GROUP INC holds $174,164,737 across 88 Biotechnology names. LGND ranks #2 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	64,251	$46,919,290
2	LGND	Ligand Pharmaceuticals Inc This page	107,859	$21,534,046
3	TNGX	Tango Therapeutics, Inc.	708,398	$14,819,686
4	MAZE	Maze Therapeutics, Inc.	481,790	$14,381,431
5	PTGX	Protagonist Therapeutics, Inc	54,178	$5,710,360
6	KRYS	Krystal Biotech, Inc.	20,285	$5,240,020
7	BMRN	Biomarin Pharmaceutical Inc	89,439	$5,052,409
8	ARWR	Arrowhead Pharmaceuticals, Inc.	79,140	$4,962,077

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,534,046	107,859	+358.8%	Shares	Defined	2026-05-06
2025-12-31	$4,445,034	23,510	+3051.5%	Shares	Defined	2026-02-05
2025-09-30	$132,145	746	+1013.4%	Shares	Defined	2025-11-05
2025-06-30	$7,616	67	+318.8%	Shares	Defined	2025-08-01
2025-03-31	$1,682	16	-57.9%	Shares	Defined	2025-04-23
2024-12-31	$4,071	38	+123.5%	Shares	Defined	2025-02-13
2023-06-30	$1,225	17	+30.8%	Shares	Defined	2023-08-10
2020-06-30	$907	13	0.0%	Shares	Defined	2020-08-05
2020-03-31	$589	13	—	Shares	Defined	2020-04-30
No filing history on record for this holder in this stock.